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Ovine Model
Carlos E. Donayre, MD1, George Kopchok, BS2, Brad Kellerman1, Gene
Reu1. 1LA BioMed Research Institute at Harbor-UCLA, Torrance, Calif;
2LA BioMed Research Institute at Harbor/UCLA, Torrance, Calif
Objectives: This was a prospective comparison of percutaneous vs an
open femoral arteriovenous (AV) ﬁstula in an ovine model.
Methods: Six femoral AV ﬁstulas were created using standard side-to-
side anastomoses with loupe magniﬁcation (group A) in an ovine model. Six
femoral percutaneous AV ﬁstulas were also created in an ovine model using
high-deﬁnition ultrasound imaging to cannulate the femoral vein and to
direct a specially designed crossing wire from the femoral vein to the adja-
cent femoral artery. A catheter designed to bring the femoral artery and
vein close together was then introduced, and computer-control heat was
applied to create a thermal resistance seal designed to hold the artery and
vein together, with a concentric aperture between the artery and vein,
creating an AV ﬁstula (group B).
Results: Both groups were survived for 15 and 30 days with duplex
ultrasound follow-up imaging of the femoral artery and vein, dimension
determination, assessment of vessel and ﬁstula patency, proximal venous
outﬂow, and histopathologic evaluation of the excised specimens (Table).
The variable data did not attain statistical signiﬁcance. Histopathologic data
conﬁrmed patency determined by ultrasound imaging and exhibited com-
parable neointimal tissue response and maturation between both methods.
Conclusions: Creation of percutaneous AV ﬁstulas was successful in a
femoral ovine model and compared favorably with ﬁstulas created using
open surgical techniques. In this model, which is prone to intimal hyperpla-
sia formation, avoidance of suture and foreign body reaction and lack of
disruption of the vascular bed at the anastomotic site may have implications
with regards to patency and ﬁstula maturation. Utilization in humans with
end stage renal disease appears feasible.
Table. Comparison percutaneous AV ﬁstula vs surgical AV ﬁstula
Femoral AV ﬁstulaVariable Surgical (n ¼ 6) Percutaneous (n ¼ 6)Arterial diameter, mm 4.0 3.4
Initial vein diameter, mm 3.4 3.3
Vein diameter at explant, mm 4.4 4.6
Initial ﬁstula length, mm 10.0 4.7
Fistula length at explant, mm 6.3 5.1
Initial ﬁstula ﬂow, mL/min NA 769
Fistula ﬂow at explant, mL/min 866 505
Patency, % 83 100A Comparison of Surgical Approaches for Cervical Rib Resection for
Neurogenic Thoracic Outlet Syndrome
Arjun Jayaraj, MD, Audra A. Duncan, MD, Manju Kalra, MD, Thomas C.
Bower, MD, Peter Gloviczki, MD. Mayo Clinic, Rochester, Minn
Objectives: The presence of a cervical rib in 1% of the general popu-
lation can often be symptomatic, causing neurogenic thoracic outlet syn-
drome (nTOS). Surgical treatment has been most commonly described
through a supraclavicular (SC) incision or a combination of SC and transax-
illary (TA) dissections. In an effort to avoid a SC incision, particularly in
young patients, completely transaxillary cervical rib resections were done
and their outcomes evaluated.
Methods: In a single-center retrospective review, we analyzed periop-
erative and outcome data on subjects undergoing cervical rib resection for
nTOS between 1994 and 2013.
Results: Of the 75 operations performed for nTOS, 40% (30 proce-
dures in 29 patients) required resection of cervical ribs in 25 women
(87%) and four men (13%). Mean age was 37 years (range, 13-68 years).
The ﬁrst and cervical ribs were removed in 24 cases, whereas only the cer-
vical was resected in six. Scalenetectomy was performed in all patients. Thir-
teen (43%) procedures were done with a SC only approach, nine (30%) with
a transaxillary (TA) only approach, and eight (27%). with both incisions (TA
+ SC). The most common perioperative complication was pneumothorax
occurring in one (8%) of SC, four (44%) of TA, and one (13%) of the TA
+ SC group. There were no instances of brachial plexus or other nerve
injury. Incidence of persistent nTOS symptoms occurred in three SC pa-
tients (23%), one TA patient (13%), and in two TA + SC patients (25%; P
¼ not signiﬁcant). Recurrence of symptoms was noted in one patient
(8%) in the SC group at the 1-year follow-up. No patient required operative
reintervention.Conclusions: Resection of cervical ribs, often in addition to ﬁrst ribs,
in treatment of nTOS can be safely done through SC, TA, or a combined
approach. In young patients, a TA incision may be considered to avoid a
neck incision, with similar outcomes to alternate approaches.
Robotic Removal of a Symptomatic Inferior Vena Cava Filter
Mark E. O’Donnell, MMedSc, MD, FRCS, Scott M. Cheney, MD, Erik P.
Castle, MD, Grant T. Fankhauser, MD, Richard J. Fowl, MD, William M.
Stone, MD, Samuel R. Money, MD. Mayo Clinic, Phoenix, Ariz
Objectives: Percutaneous inferior vena cava (IVC) ﬁlter placement
has successfully replaced ligation or interruption procedures as the optimal
interventional modality for pulmonary embolism prophylaxis. However,
IVC ﬁlter deployment is not without risk and may be associated with punc-
ture site bleeding, higher venous thrombotic or occlusion rates, as well as
ﬁlter migration and perforation.
Methods: We present the successful robotic removal of a symptom-
atic IVC ﬁlter.
Results: A 23-year-old woman presented with deteriorating severe
right lower back and right upper quadrant pain with associated left lower ex-
tremity discomfort. She had a previous history of left lower extremity deep
venous thrombosis (DVT) 5 years earlier. She had been prescribed oral con-
traceptives for 2 months but was otherwise well, with no other prothrom-
botic risk factors. Venous duplex imaging conﬁrmed left iliac vein
thrombosis. She proceeded to left common iliac vein stenting for presumed
May-Thurner syndrome combined with retrievable IVC ﬁlter insertion.
Warfarin therapy was continued for 2 months. Two attempts to retrieve
the IVC ﬁlter failed the following year due to ﬁlter migration and perforation
of struts through the IVC wall. Clinically, she had mild generalized abdom-
inal tenderness and no evidence of any lower extremity arteriovenous pathol-
ogy. Computed tomography venography identiﬁed three separate ﬁlter
struts that had perforated the IVC adjacent to the duodenum and lumbar
vertebrae wall. Owing to severe ongoing pain, the patient was scheduled
for robotic removal of the IVC ﬁlter. Patient positioning was completed us-
ing a modiﬁed 30 ﬂank position with slight table ﬂexion and reverse Tren-
delenburg positioning. After creation of the pneumoperitoneum, a 12-mm
camera port was inserted, followed by insertion of the remaining robotic
ports under direct vision (5 mm  1.8 mm  3 and 12 mm  1 mm).
Key procedural steps included mobilization of the duodenum and right co-
lon, IVC dissection using the split-and-roll technique, vascular control of the
IVC, creation of the cavotomy, mobilization and robotic fracture of the IVC
ﬁlter struts, and removal of the IVC ﬁlter, followed by closure of the cavot-
omy. The patient made an uneventful recovery and was discharged well on
postoperative day 2. She remains symptomatically well 6 months later.
Conclusions: After failed percutaneous retrieval, we suggest robotic
removal of IVC foreign bodies as a safe and less morbid technique that pro-
vides shorter recovery and improved patient quality of life.
Comparison of a Vascular Study Group of New England (VSGNE)
Risk Prediction Model With the Established Risk Prediction Models
of In-Hospital Mortality After Elective Abdominal Aortic Aneurysm
(AAA) Repair
Mohammad H. Eslami, MD1, Denis Rybin, PhD2, Gheorghe Doros, PhD2,
Jeffrey Kalish, MD1, Alik Farber, MD1. 1Boston University School of Medicine,
Boston, Mass; 2Boston University School of Public Health, Boston, Mass
Objectives: Elective abdominal aortic aneurysm (AAA) repair can lead
to in-hospital mortality, but no agreement exists on the most accurate pre-
dictive model for in-hospital mortality. The purpose of this study was to
develop a risk prediction model using Vascular Study Group of New En-
gland (VSGNE) data and compare that with established models.
Methods: VSGNE data (2003-2013) were queried for patients un-
dergoing elective AAA repair by open (OAR) or endovascular (EVAR) tech-
niques. Clinical variables, including known predictors of mortality, were
included in a full prediction model. Backward elimination with an a-level
of .5 was used to construct a parsimonious model. This model (VSGNE)
was then compared with established models based on the scope of VSGNE
data collection: Medicare, Glasgow Aneurysm Score (GAS), and Vascular
Governance North West (VGNW). Vuong test was performed to compare
the ﬁt of models. Model discrimination was compared in equally sized risk-
group VSGNE terciles.
Results: The overall mortality rate for 4597 elective AAA patients was
1.5%, with a signiﬁcantly higher mortality rate for OAR (2.7% vs 0.7%; P <
.001). The Table shows the parsimonious model. The discriminating ability
of the VSGNE model was high (C statistic ¼ 0.812) and corrected slightly
to 0.782 after internal validation. Vuong tests yielded signiﬁcant overall ﬁt
difference favoring the VSGNE model over all three models and Medicare
(C-statistic ¼ 0.761) and VGNW (C-statistic ¼ 0.760) to GAS (C-statistic
¼ 0.681). VGNW and Medicare models performed better than GAS in
predicting mortality among risk-group terciles (Fig).
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the best among this patient population. The Medicare and VGNW models
both showed good discrimination.
Fig. ROC curves of VSGNE predicting mortality after elective
AAA versus established risk prediction models.
Table. In-hospital mortality after elective AAA: Parsimonious 0.5 level
(C ¼ 0.812)
Odds ratio Conﬁdence limitVariable PAdjusted Lower UpperOpen infrarenal/above one
renal clamp vs endo3.8700 2.0485 7.3112 <.0001Open above both renals/
supraceliac clamp vs endo8.6776 4.3051 17.4910 <.0001Age 1.0790 1.0368 1.1228 .0002
Female vs male 1.7280 1.0023 2.9794 .0491
Body mass index 0.9749 0.9260 1.0264 .3337
Current smoking: yes vs no 0.6942 0.3065 1.5720 .3814
Myocardial disease 1.7219 1.0019 2.9593 .0492
Cerebrovascular disease 2.0902 0.9933 4.3984 .0521
Congestive heart failure 1.7298 0.8520 3.5122 .1294
Chronic obstructive pulmonary
disease
2.4737 1.4262 4.2905 .0013Creatinine 1.3210 0.9575 1.8225 .09Long-Term Surveillance of EVAR Patients With Ultrasound is Safe
and Effective
William C. Wu, MD, Raymond Eid, MD, Robert Hacker, MD, Michel S.
Makaroun, MD, Rabih A. Chaer, MD. University of Pittsburgh Medical
Center, Pittsburgh, Pa
Objectives: Color ﬂow duplex ultrasound (CDU) surveillance is an
accepted alternative to computed tomography (CT) after endovascular
repair of abdominal aortic aneurysms (EVAR). However, the long-term
effectiveness and safety of yearly CDU-only surveillance is not yet well
deﬁned. The purpose of this study was to evaluate the safety and effective-
ness of CDU follow-up in the long-term.
Methods: Patients who underwent EVAR between January 1, 2005,
and December 31, 2010, with no routine CT after 1 year and followed up
with CDU as the primary surveillance method for at least 2 years, were
included. Subsequent CT scans were only selectively obtained for enlarging
sac size or suspected type I or III endoleak. The majority of type II endo-
leaks were monitored with CDU only.Results: Reviewed were 169 patients switched to CDU follow-up
no later than 1 year after EVAR and followed up for 2 to 8 years, with
a mean of 4.5 6 1.3 years (53.6 6 16.1 months). They included two pa-
tients with limb infolding treated with extra stent grafts and 26 patients
with known prior endoleaks detected during the ﬁrst year, with two
type IB and one type II endoleaks already treated. During CDU follow-
up, 27 patients were identiﬁed to have a new endoleak, seven of whom
required a total of eight reinterventions with endovascular stent graft
extension or coiling, four after a conﬁrmatory CT and four without.
One patient with a renal artery stenosis at 3 years underwent angiography
and was found to have a renal artery occlusion caused by a barb fracture
and migration without endoleak. Only six patients underwent a CT to
further evaluate ﬁndings on CDU. There were no ruptures, limb occlu-
sions, or abdominal aortic aneurysm-related deaths throughout the
follow-up period.
Conclusions: After the 1-year postoperative CT, a switch to CDU as
the primary means of follow-up is a safe and effective surveillance strategy
after EVAR.
Comparative Safety of Endovascular and Open Surgical Repair of
Abdominal Aortic Aneurysms in Low-Risk Patients
Jeffrey J. Siracuse, MD, Heather L. Gill, MD, Ashley R. Graham, Darren B.
Schneider, MD, Peter H. Connolly, MD, Art Sedrakyan, MD, PhD,
Andrew J. Meltzer, MD. Weill Cornell Medical College, New York, NY
Objectives: The prevalence of signiﬁcant comorbidities among pa-
tients with abdominal aortic aneurysms (AAAs) has contributed to wide-
spread enthusiasm for endovascular AAA repair (EVAR). However, the
advantages of EVAR in patients at low risk for open surgical repair (OSR)
remain unclear. Our objective was to compare perioperative outcomes of
EVAR vs OSR in low-risk patients.
Methods: Patients undergoing EVAR or OSR for infrarenal AAA
were identiﬁed in the 2007 to 2010 National Surgical Quality Improvement
Program data sets. AAA-speciﬁc risk stratiﬁcation, using the Medicare Aneu-
rysm Score (MAS), was used to create matched low-risk (MAS <3) cohorts.
Perioperative morbidity and mortality were assessed via crude comparisons
of matched groups and regression models.
Results: Of 11,753 patients undergoing EVAR, 4339 (37%) were
deemed low risk (MAS <3). A matched cohort of 1576 low-risk pa-
tients was developed from 3804 (41%) undergoing OSR. By deﬁnition,
the low-risk cohorts included only males aged <75 years without signif-
icant cardiac, pulmonary, or vascular comorbidities. Mean age in both
low-risk groups was 67 6 6 years (P ¼ not signiﬁcant). EVAR patients
were more likely to be obese (40.8% vs 30.4%; P < .001), diabetic
(16.2% vs 13.1%; P ¼ .005), and have a history of cardiac intervention
(24.3% vs 19.2%; P < .001), or surgery (22.6% vs 19.7%; P ¼ .02), ste-
roid use (3.6% vs 2.0%; P ¼ .002), and bleeding disorders (8.7% vs
5.9%; P ¼ .001). There were no other differences between the matched
cohorts. EVAR was associated with reduced 30-day mortality (0.6% vs
1.5%; P < .01) and reduced rates of major complications, including
sepsis (0.7% vs 3.2%; P < .01), unplanned intubation (1.0% vs 5.4%;
P < .001), pneumonia (0.8% vs 6.1%; P < .001), acute renal failure
(0.4% vs 2.7%; P < .001), and early reoperation (3.7% vs 6.0%), p 4
units (2.0% vs 13.0%; P < .001), cardiac arrest (0.2 vs 0.8;
P ¼ .001), neurologic deﬁcits (0.2% vs 0.5%; P ¼ .032), and urinary
tracts infections (1.2% vs 2%; P ¼ .02).
Conclusions: Our results demonstrate that even among those pa-
tients at low risk for OSR, EVAR is associated with reduced periopera-
tive mortality and major complications. Although clinical decisions
must account for safety and long-term effectiveness, the short-term
beneﬁt of EVAR is evident even among patients at the lowest risk for
OSR.
Age at Revascularization Does Not Predict Need for Reintervention in
Patients With Femoropopliteal Occlusive Disease
Daniel J. Torrent, MD, Jill N. Zink, MD, William M. Bogey, Jr, MD,
Charles S. Powell, MD, Frank M. Parker, DO, Dean J. Yamaguchi, MD,
Nishika S. Patel, Avery G. Colomb, Aseem G. Kaul, Michael C.
Stoner, MD. East Carolina University, Greenville, NC
Objectives: Conventional wisdom holds that patients with need for
intervention at a younger age have more aggressive disease, although there
is a paucity of supportive literature. The purpose of this study is to evaluate
this assumption.
Methods: A retrospective cohort of patients undergoing endovascu-
lar or open revascularization for femoropopliteal occlusive disease
(FPOD) over a 4-year period was assembled. Demographic information,
comorbidities, disease characteristics, and time to last follow-up or death
were recorded. Time to major revascularization or amputation or major
